MegaLive Hemovin Capsule
MegaLive Hemovin Capsule : Product registered in Malaysia. This registration does not constitute authorisation for sale in France or the European Union. It does not demonstrate the safety or efficacy of the product.
NPRA, Malaysian pharmaceutical products register, retrieved 27 October 2026.
Ministry of Health Malaysia / NPRA, Pharmaceutical Products, CC BY 4.0
- Registration number
- MAL17126069TC
- Type
- Natural product
- Published status
- PRODUCT APPROVED
- Licence holder
- MegaLive BioSciences Sdn Bhd
- Manufacturer
- GN NEUTRICEUTICALS SDN. BHD.
- Registration period starting
- 2022-12-22
- Published validity end
- 2027-12-22
The foreign register category does not determine the regulatory category of the product in France.
French and European references for recognised ingredients
No point flagged by the rules applied to recognised ingredients.
Unidentified ingredients are not assessed. The absence of a signal does not establish product compliance.
Published composition
| Published ingredient | Published text and quantity | Identified nutrient or substance |
|---|---|---|
| Aesculus hippocastanum | Aesculus hippocastanum[150 mg,500 mg] | Not identified |
| Ruscus aculeatus | Ruscus aculeatus[100 mg] | Not identified |
| Crataegus pinnatifida | Crataegus pinnatifida[100 mg,500 mg] | Not identified |
| Centella asiatica | Centella asiatica[50 mg,500 mg] | Not identified |
The imported data provide no usable daily dosage. No daily dose is estimated and no comparison with dose limits is performed. A published quantity may refer to a preparation or an unspecified unit. Chinese names are retained without translation.
Original register data
View published fields and their variants
- Active ingredients
- Aesculus hippocastanum[150 mg,500 mg],Ruscus aculeatus[100 mg],Crataegus pinnatifida[100 mg,500 mg],Centella asiatica[50 mg,500 mg]
- Valid until
- 2027-12-22
- Registration date
- 2022-12-22
- Published description
- NATURAL PRODUCT
- Licence holder
- MegaLive BioSciences Sdn Bhd
- Producer
- GN NEUTRICEUTICALS SDN. BHD.
- Published name
- MegaLive Hemovin Capsule
- Published reference
- 201708290729T
- Registration number
- MAL17126069TC
- Published status
- PRODUCT APPROVED
Official source
View the official register, number MAL17126069TC
Ministry of Health Malaysia / NPRA, Pharmaceutical Products, CC BY 4.0
Official warnings (Health Canada)
Health Canada publishes warnings on these ingredients:
- Aesculus hippocastanum
Read the warning, when it applies and the studies cited
Horse Chestnut - Aesculus Hippocastanum
Route of administration: Oral (Bradley 2006; ESCOP 2003)
Cautions and warnings
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding (Brinker 2010; Mills and Bone 2005).
2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
Known adverse reactions
When using this product you may experience headache, dizziness, gastric irritation, or itchiness (Bradley 2006; Mills and Bone 2005; ESCOP 2003).
3 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
They concern the ingredient, not this product or its dose. They do not replace medical advice.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.